Apart from electroencephalogram biofeedback and electrical brain stimulation adopted for maintenance treatment, the study utilizes ultra-low frequency transcranial magnetic stimulation (ULF-TMS) for initial γ-aminobutyric acid (GABA) stimulation. The cocktail therapy starts after the primary efficacy endpoint, and concomitant therapy is adopted throughout the study.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Changes in Leukocyte and Components' Quantities
Timeframe: 24 days
Changes in Leukocyte Components' Ratios
Timeframe: 24 days
Quantity Changes in Megakaryocyte-Erythroid Progenitor
Timeframe: 24 days
Changes in Hemoglobin Distribution
Timeframe: 24 days
Changes in Mean Corpuscular Hemoglobin
Timeframe: 24 days
Changes in Hematocrit
Timeframe: 24 days
Changes in Plateletcrit
Timeframe: 24 days
Red cell Distribution Width Coefficient of Variation
Timeframe: 24 days
Changes in Particulate Matter Sizes
Timeframe: 24 days
Changes in Total Lipid Quantities
Timeframe: 24 days
Changes in Apolipoproteina
Timeframe: 24 days
Changes in Lipoprotein (a)
Timeframe: 24 days